Liraglutide + metformin combination therapy investigated for improving cardiac and metabolic markers in CAD and T2D
The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
Abstract
A randomized, double-blind, crossover study is investigating if liraglutide added to metformin improves beta-cell function, LVEF, and blood pressure in CAD patients with T2D.